Vascular Biogenics Balance Sheet Health
Financial Health criteria checks 6/6
Vascular Biogenics has a total shareholder equity of $19.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $24.6M and $5.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$24.26m |
Equity | US$19.24m |
Total liabilities | US$5.41m |
Total assets | US$24.65m |
Recent financial health updates
Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation
May 18Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?
Dec 24Recent updates
VBL Therapeutics receives non-compliance letter from Nasdaq
Sep 01VBL Therapeutics GAAP EPS of -$0.12
Aug 15VBL Therapeutics' late-stage trial for ovarian cancer treatment does not meet main goals
Jul 19Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation
May 18Vascular Biogenics Trial Nears Full Enrollment, Price Could Jump
Sep 03How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?
Mar 17How Much Of Vascular Biogenics Ltd. (NASDAQ:VBLT) Do Insiders Own?
Jan 28VBL Therapeutics expands the ovarian cancer trial in Europe
Dec 29Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?
Dec 24Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Have Been Cutting Their Estimates
Nov 19VBL Therapeutics EPS beats by $0.01, misses on revenue
Nov 16Financial Position Analysis
Short Term Liabilities: VBLT's short term assets ($24.5M) exceed its short term liabilities ($5.3M).
Long Term Liabilities: VBLT's short term assets ($24.5M) exceed its long term liabilities ($108.0K).
Debt to Equity History and Analysis
Debt Level: VBLT is debt free.
Reducing Debt: VBLT had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VBLT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: VBLT has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 15.7% each year.